Candidate cell substrates, vaccine production, and transmissible spongiform encephalopathies

Emerging Infectious Diseases

Volumn 17, Issue 12, 2011, Pages 2262-2269

  Piccardo, Pedro ^a,b   Cervenakova, Larisa ^c   Vasilyeva, Irina ^c   Yakovleva, Oksana ^c   Bacik, Igor ^b   Cervenak, Juraj ^b   McKenzie, Carroll ^c   Kurillova, Lubica ^b   Gregori, Luisa ^b   Pomeroy, Kitty ^b   Asher, David M ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BOVINE SPONGIFORM ENCEPHALOPATHY; BOVINE SPONGIFORM ENCEPHALOPATHY AGENT; BRAIN HOMOGENATE; CELL STRAIN; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; CREUTZFELDT JAKOB DISEASE AGENT; DISEASE PREDISPOSITION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MOUSE; NEUROPIL; NONHUMAN; PRION DISEASE; TISSUE CULTURE; VIRUS INFECTIVITY; VIRUS STRAIN; VIRUS TITRATION; VIRUS TRANSMISSION;

EID: 84930485360     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1712.110607     Document Type: Article

References (34)

1. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136-44. doi:10.1126/science.6801762
2. Asher DM. The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics [review]. Dev Biol Stand. 1999;100:103-18.
3. Aguzzi A, Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell. 2004;116:313-27. doi:10.1016/S0092-8674(03)01031-6
4. Hewitt PE, Llewelyn CA, Mackenzie J, Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang. 2006;91:221-30. doi:10.1111/j.1423-0410.2006.00833.x
5. UK Health Protection Agency. Fourth case of transfusion-associated variant-CJD infection. Health Protection Report. 2007 [cited 2011 Sep 12]. http://www.hpa.org.uk/hpr/archives/2007/news2007/news0307.htm#cjd
6. Peden A, McCardle L, Head MW, Love S, Ward HJ, Cousens SN, et al. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia. 2010;16:296-304. doi:10.1111/j.1365-2516.2009.02181.x
7. Barron RM, Campbell SL, King D, Bellon A, Chapman KE, Williamson RA, et al. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPsc in vivo. J Biol Chem. 2007;282:35878-86. doi:10.1074/jbc. M704329200
8. P, Manson JC, King D, Ghetti B, Barron RM. Accumulation of PrP in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A. 2007;104:4712-7. doi:10.1073/ pnas.0609241104
9. Manuelidis L, Liu Y, Mullins B. Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein. J Cell Biochem. 2009;106:220-31. doi:10.1002/jcb.21988
10. Moore RA, Taubner LM, Priola SA. Prion protein misfolding and disease. Curr Opin Struct Biol. 2009;19:14-22. doi:10.1016/j. sbi.2008.12.007
11. Vorberg I, Raines A, Priola SA. Susceptibility of common fibroblast cell lines to transmissible spongiform, encephalopathy agents. J Infect Dis. 2004;189:431-9. doi:10.1086/381166
12. Clarke MC, Millson GC. Infection of a cell line of mouse L fibroblasts with scrapie agent. Nature. 1976;261:144-5. doi:10.1038/261144a0
13. Cashman NR. Transmissible spongiform encephalopathies: vaccine issues. In: Brown F, Lewis AM jr, Peden K, Krause P, editors. Evolving scientific and regulatory perspectives on cell subtrates for vaccine development. Basel (Switzerland): Karger; 2001.
14. Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, Mc-Shane L, Drohan WN, et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion. 2003;43:1687-94. doi:10.1046/j.0041-1132.2003.00586.x
15. P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion. 1998;38:810-6. doi:10.1046/ j.1537-2995.1998.38998408999.x
16. Gregori L, McCombie N, Palmer D, Birch P, Sowemimo-Coker S, Giulivi A, et al. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet. 2004;364:529-31. doi:10.1016/S0140-6736(04)16812-8
17. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, et al. Transmission of prion diseases by blood transfusion. J Gen Virol. 2002;83:2897-905.
18. Hogan RN, Brown P, Heck E, Cavanagh HD. Risk of prion disease transmission from ocular donor tissue transplantation. Cornea. 1999;18:2-11. doi:10.1097/00003226-199901000-00002
19. Food and Drug Administration. Bovine derived materials used in vaccine manufacturing questions and answers. Last updated June 18, 2009 [cited 2011 Sep 12]. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm143521.htm
20. Centers for Disease Control and Prevention. BSE (bovine spongiform encephalopathy, or mad cow disease). Last updated March 17, 2011 [cited 2011 Sep 12]. http://www.cdc.gov/ncidod/dvrd/bse/
21. Minor P, Newham J, Jones N, Bergeron C, Gregori L, Asher D, et al. Standards for the assay of Creutzfeldt-Jakob disease specimens. J Gen Virol. 2004;85:1777-84. doi:10.1099/vir.0.79959-0
22. Piccardo P, Cervenak J, Yakovleva O, Gregori L, Pomeroy K, Cook A, et al. Squirrel monkeys (Saimiri sciureaus) infected with the agent of bovine spongiform encephalopathy develop tau pathology. J Comp Pathol. 2011. In press.
23. I, Raines A, Priola SA. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J Biol Chem. 2004;279:29218-25. doi:10.1074/jbc. M402576200
24. Polymenidou M, Trusheim H, Stallmach L, Moos R, Julius C, Miele G, et al. Canine MDCK cell lines are refractory to infection with human and mouse prions. Vaccine. 2008;26:2601-14. doi:10.1016/j. vaccine.2008.03.035
25. National Biological Standards Board. NBSB annual report and accounts. 2004 [cited 2011 Sep 12]. http://www.nibsc.ac.uk/PDF/NBSB_annual_report_200304.pdf
26. Bosque PJ, Prusiner SB. Cultured cell sublines highly susceptible to prion infection. J Virol. 2000;74:4377-86. doi:10.1128/ JVI.74.9.4377-4386.2000
27. Mahal SP, Baker CA, Demczyk CA, Smith EW, Julius C, Weissmann C. Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci U S A. 2007;104:20908-13. doi:10.1073/ pnas.0710054104
28. Manuelidis L, Yu Z, Barquero N, Mullins B. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25- nm virus-like particles. Proc Natl Acad Sci U S A. 2007;104:1965-70. doi:10.1073/pnas.0610999104
29. Rubenstein R, Carp RI, Callahan SM. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J Gen Virol. 1984;65:2191-8. doi:10.1099/0022-1317-65-12-2191
30. Cervenakova L, Akimov S, Vasilyeva I, Yakovleva O, Mckenzie C, Cervenak J, et al. Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells. Transfusion. 2011;51:1755-68.
31. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec. 1987;121:419-20. doi:10.1136/vr.121.18.419
32. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and species barrier [review]. Philos Trans R Soc Lond B Biol Sci. 1994;343:405-11. doi:10.1098/rstb.1994.0036
33. Asher DM. Gibbs CJ Jr, Sulima MP, Bacote A, Amyx H, Gajdusek DC. Transmission of human spongiform encephalopathies to experimental animals: comparison of the chimpanzee and squirrel monkey. Dev Biol Stand. 1993;80:9-13.
34. Plinston C, Hart P, Chong A, Hunter N, Foster J, Piccardo P, et al. Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy following passage in sheep. J Virol. 2011;85:1174-81. doi:10.1128/JVI.01578-10